{"_links": {"parentClass": {"href": "/mdr/cdashig/2-2/classes/Findings", "title": "Findings", "type": "Class"}, "parentProduct": {"href": "/mdr/cdashig/2-2", "title": "Clinical Data Acquisition Standards Harmonization Implementation Guide for Human Clinical Trials Version 2.2", "type": "Implementation Guide"}, "priorVersion": {"href": "/mdr/cdashig/2-1/domains/MS", "title": "Microbiology Susceptibility Test", "type": "CDASH Domain"}, "scenarios": [{"href": "/mdr/cdashig/2-2/scenarios/MS.CentralProcessing", "title": "Central Processing", "type": "CDASH Scenario"}, {"href": "/mdr/cdashig/2-2/scenarios/MS.LocalProcessing", "title": "Local Processing", "type": "CDASH Scenario"}], "self": {"href": "/mdr/cdashig/2-2/domains/MS", "title": "Microbiology Susceptibility", "type": "CDASH Domain"}}, "description": "A findings domain that represents drug susceptibility testing results only. This includes phenotypic testing (where drug is added directly to a culture of organisms) and genotypic tests that provide results in terms of susceptible or resistant. Drug susceptibility testing may occur on a wide variety of non-host organisms, including bacteria, viruses, fungi, protozoa and parasites. (Source: CDISC Controlled Terminology, DOMAIN, C61531, 2021-06-25)", "label": "Microbiology Susceptibility", "name": "MS", "ordinal": "22"}
